CN103007079B - Chinese patent medicine for treating gout - Google Patents
Chinese patent medicine for treating gout Download PDFInfo
- Publication number
- CN103007079B CN103007079B CN201210522773.7A CN201210522773A CN103007079B CN 103007079 B CN103007079 B CN 103007079B CN 201210522773 A CN201210522773 A CN 201210522773A CN 103007079 B CN103007079 B CN 103007079B
- Authority
- CN
- China
- Prior art keywords
- chinese patent
- patent medicine
- gout
- rhizoma
- gentiana
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a Chinese patent medicine for treating gout. The Chinese patent medicine comprises the following raw materials by weight ratio: 3-5 of gentiana macrophylla, 3-5 of gentiana dahurica fisch, 3-8 of liquorice, 4-15 of cortex moutan, 15-20 of Herba Artemisiae Capillaris, 5-20 of radix paeoniae rubra, 8-15 of Chinese Angelica, 30-40 of Plantain Herb, 2-10 of rhizoma coptidis, 15-18 of Juncus roemerianus, 15-30 of plaster stone, 6-12 of rhizoma anemarrhenae, 25-30 of Lalang Grass Rhizome, 8-15 of polyporus, 5-10 of Ludwigia octovalvis, and 9-15 of phellodendron. The Chinese patent medicine has a good treatment effect on gout, can reduce uric acid, and has the advantages of fast efficacy, safety, no toxic or side effect and no recurrence.
Description
Technical field
The present invention relates generally to tcm field, relates in particular to a kind of Chinese patent medicine for the treatment of gout.
Background technology
Gout is due to purine metabolic disturbance, and hyperuricemia causes uric acid crystal to be deposited on joint and subcutaneous tissue and a kind of disease of causing.Take clinically that hyperuricemia, characteristic acute arthritis are shown effect repeatedly, gout calculus is feature, severe patient can cause joint deformity and dysfunction, acute obstruction nephropathy or gouty nephropathy.Western medical treatment gout adopts the method for acid discharge, antiinflammatory more, can not systematically deal with problems, and expense is high, side effect is large comprehensively, easily produces diarrhoea, damage liver function etc.Using Chinese herbal treatment gout is the work of always studying, but current treatment can only alleviate patient suffering, can not effect a radical cure.
Summary of the invention
The object of the invention is for a kind of Chinese patent medicine for the treatment of gout is provided, cost that can be lower treatment gout, and good effect, instant effect, be difficult for recurrence.
The present invention is achieved by the following technical solutions:
Treat a Chinese patent medicine for gout, the weight proportion of its each raw material is: Gentiana macrophylla Pall. 3-5, Gentiana dahurica 3-5, Radix Glycyrrhizae 3-8, Cortex Moutan 4-15, Herba Artemisiae Scopariae 15-20, Radix Paeoniae Rubra 5-20, Radix Angelicae Sinensis 8-15, Herba Plantaginis 30-40, Rhizoma Coptidis 2-10, Medulla Junci 15-18, Gypsum Fibrosum 15-30, Rhizoma Anemarrhenae 6-12, Rhizoma Imperatae 25-30, Polyporus 8-15, Herba Ludwigiae Prostratae 5-10, Cortex Phellodendri 9-15.
Treat a Chinese patent medicine for gout, the optimum weight proportioning of its each raw material is: Gentiana macrophylla Pall. 4, Gentiana dahurica 3, Radix Glycyrrhizae 5, Cortex Moutan 10, Herba Artemisiae Scopariae 17, Radix Paeoniae Rubra 15, Radix Angelicae Sinensis 13, Herba Plantaginis 35, Rhizoma Coptidis 7, Medulla Junci 16, Gypsum Fibrosum 24, the Rhizoma Anemarrhenae 9, Rhizoma Imperatae 28, Polyporus 12, Herba Ludwigiae Prostratae 7, Cortex Phellodendri 12.
Described Chinese patent medicine is a kind of capsule.
Advantage of the present invention is:
The Chinese patent medicine that the inventive method is made, has good curative effect to treatment gout, by clinical practice and observation, adopt Chinese patent medicine of the present invention patient's pain relieving on the two, uric acid resisting on the 20th, instant effect, has no side effect and is difficult for recurrence.
The specific embodiment
Treat a Chinese patent medicine for gout, the weight of its each raw material components (g) is: Gentiana macrophylla Pall. 4, Gentiana dahurica 3, Radix Glycyrrhizae 5, Cortex Moutan 10, Herba Artemisiae Scopariae 17, Radix Paeoniae Rubra 15, Radix Angelicae Sinensis 13, Herba Plantaginis 35, Rhizoma Coptidis 7, Medulla Junci 16, Gypsum Fibrosum 24, the Rhizoma Anemarrhenae 9, Rhizoma Imperatae 28, Polyporus 12, Herba Ludwigiae Prostratae 7, Cortex Phellodendri 12.
Take above-mentioned each raw material and mix, cleaning, drying, add 2L water, and 1 hour at a simmer, big fire was decocted 2 hours; Get decocting liquid and cross 150 mesh sieves, the rear clear paste that is concentrated into relative density 1.15 with concentrator, gets 2/3 clear paste and at 120 ℃, sprays dryly, obtains clear paste powder, powder is mixed to granulation with residue 1/3 clear paste; Granule is made to the capsule of 0.4g/ grain with capsule-filling agent.Every day three times, take for each two.
For checking therapeutic effect of the present invention, spy carries out following experimental technique, adopts random packet, control experiment method.
Choose 40 routine patient with gout, this 40 routine patient is divided into two groups at random.Male's 13 examples in matched group 20 examples, women's 7 examples, age 38-69 year, 43 years old mean age.In treatment group 20 examples, male's 11 examples, women's 9 examples, age 33-70 year, 46 years old mean age.
Treatment standard is the criterion of therapeutical effect of gout in < < disease of tcm Standardization of diagnosis and curative effect > >:
Cure: transference cure, lab testing is normal.
Take a turn for the better: arthroncus is subdued, pain relief, lab testing is improved.
Do not heal: symptom and lab testing are unchanged.
For matched group, adopt common Western medicine method treatment.The capsule treatment of the present invention that gives for treatment group.
Observe 2 months, therapeutic outcome is as follows:
| ? | Cure | Take a turn for the better | Do not heal |
| Treatment group number | 14 | 6 | 0 |
| Contrast groups number | 6 | 10 | 4 |
Now provide following model case to confirm:
Case 1
Zhang, man, 45 years old.Suffer from gout 2 years, adopt the various ways treatments such as doctor trained in Western medicine, cost is high and curative effect is all not obvious., there is red and swollen phenomenon in ankle joint hurt like hell, often wake up with a start night, lives very inconvenient.Take capsule of the present invention after 2 days, pain relief, after 20 days, patient's activity freely, during do not feel sick, the side effect such as vomiting, and so far without recurring.
Case 2
Wu, female, 41 years old.Suffer from gout 1 year, there is swelling, stiff, lopsided in finger-joint, just as stone, asymmetric, and size is also inconsistent, during outbreak, has an intense pain.Adopt multiple acupuncture-moxibustion, traction therapeutic, curative effect is all not obvious.Articulations digitorum manus or red and swollen, deformity is ugly.Take capsule of the present invention after 2 days, redness slowly alleviates, and after 20 days, patient points recovery does not normally have deformity, no longer pain and so far without recurrence.
Case 3
Lin, female, 42 years old.Suffer from gout 3 years, there is swelling, stiff, lopsided in finger-joint, during outbreak, has an intense pain.Articulations digitorum manus or red and swollen, deformity is ugly.Take capsule of the present invention after 2 days, redness slowly alleviates, and after 20 days, patient points and recovers normal, no longer pain and so far without recurring.
Claims (3)
1. a Chinese patent medicine for the treatment of gout, is characterized in that: the weight proportion of each raw material is: Gentiana macrophylla Pall. 3-5, Gentiana dahurica 3-5, Radix Glycyrrhizae 3-8, Cortex Moutan 4-15, Herba Artemisiae Scopariae 15-20, Radix Paeoniae Rubra 5-20, Radix Angelicae Sinensis 8-15, Herba Plantaginis 30-40, Rhizoma Coptidis 2-10, Medulla Junci 15-18, Gypsum Fibrosum 15-30, Rhizoma Anemarrhenae 6-12, Rhizoma Imperatae 25-30, Polyporus 8-15, Herba Ludwigiae Prostratae 5-10, Cortex Phellodendri 9-15.
2. a kind of Chinese patent medicine for the treatment of gout according to claim 1, is characterized in that: the weight proportion of each raw material is: Gentiana macrophylla Pall. 4, Gentiana dahurica 3, Radix Glycyrrhizae 5, Cortex Moutan 10, Herba Artemisiae Scopariae 17, Radix Paeoniae Rubra 15, Radix Angelicae Sinensis 13, Herba Plantaginis 35, Rhizoma Coptidis 7, Medulla Junci 16, Gypsum Fibrosum 24, the Rhizoma Anemarrhenae 9, Rhizoma Imperatae 28, Polyporus 12, Herba Ludwigiae Prostratae 7, Cortex Phellodendri 12.
3. a kind of Chinese patent medicine for the treatment of gout according to claim 1 and 2, is characterized in that: described Chinese patent medicine is a kind of capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210522773.7A CN103007079B (en) | 2012-12-08 | 2012-12-08 | Chinese patent medicine for treating gout |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210522773.7A CN103007079B (en) | 2012-12-08 | 2012-12-08 | Chinese patent medicine for treating gout |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103007079A CN103007079A (en) | 2013-04-03 |
| CN103007079B true CN103007079B (en) | 2014-05-07 |
Family
ID=47956542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210522773.7A Expired - Fee Related CN103007079B (en) | 2012-12-08 | 2012-12-08 | Chinese patent medicine for treating gout |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103007079B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106039113A (en) * | 2016-07-17 | 2016-10-26 | 徐琛 | Traditional Chinese medicine prescription for treating gout |
| CN111068007A (en) * | 2019-12-14 | 2020-04-28 | 袁图春 | Chinese patent medicine for treating gout |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1196254A (en) * | 1998-05-05 | 1998-10-21 | 胡晓斌 | Pill for treating arthritis and its compounding method |
| CN101347605A (en) * | 2008-08-15 | 2009-01-21 | 北京和润创新医药科技发展有限公司 | Chinese medicinal composition for treating gout and preparation method and application thereof |
| CN102240372A (en) * | 2011-06-21 | 2011-11-16 | 武汉市中医医院 | Medicine for treating gouty arthritis and hyperuricemia and preparation method thereof |
-
2012
- 2012-12-08 CN CN201210522773.7A patent/CN103007079B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1196254A (en) * | 1998-05-05 | 1998-10-21 | 胡晓斌 | Pill for treating arthritis and its compounding method |
| CN101347605A (en) * | 2008-08-15 | 2009-01-21 | 北京和润创新医药科技发展有限公司 | Chinese medicinal composition for treating gout and preparation method and application thereof |
| CN102240372A (en) * | 2011-06-21 | 2011-11-16 | 武汉市中医医院 | Medicine for treating gouty arthritis and hyperuricemia and preparation method thereof |
Non-Patent Citations (6)
| Title |
|---|
| 唐贞力.茵陈五苓散治疗急性痛风性关节炎98例.《安徽中医临床杂志》.2002,第14卷(第6期),464. |
| 张荒生治疗痛风;王进军;《实用中医内科杂志》;20061231;第20卷(第1期);23 * |
| 朱君 * |
| 王进军.张荒生治疗痛风.《实用中医内科杂志》.2006,第20卷(第1期),23. |
| 等.痛风的中药治疗研究进展.《辽宁中医药大学学报》.2008,第10卷(第10期),62-64. * |
| 茵陈五苓散治疗急性痛风性关节炎98例;唐贞力;《安徽中医临床杂志》;20021231;第14卷(第6期);464 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103007079A (en) | 2013-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101130030B (en) | Medicine composition for treating nephropathy and uses of the same | |
| CN102579913A (en) | Traditional Chinese medicine composition for treating gouty arthritis | |
| CN102228604A (en) | Traditional Chinese medicine composition for treating porcine diarrhea, and preparation method thereof | |
| US10653746B2 (en) | Medicament for use in treating gout | |
| CN103007079B (en) | Chinese patent medicine for treating gout | |
| CN104042737A (en) | External medicinal composition for treating acute eczema and preparation method thereof | |
| CN102631454B (en) | Externally used traditional Chinese medicine for curing fracture postoperation synarthrophysis | |
| CN104352722A (en) | Traditional Chinese medicine granules for treating chronic constipation and preparation method thereof | |
| CN103446350A (en) | Traditional Chinese medicine for treating chronic appendicitis | |
| CN103479947B (en) | The preparation method of control constipation medicine | |
| CN102225118B (en) | Blood-activating wind-dispelling liquid | |
| CN104127776A (en) | Traditional Chinese medicine for treating ancylostomiasis | |
| CN103638407A (en) | External medicinal liquor for treating psoriasis and preparation method thereof | |
| CN102038830A (en) | Traditional Chinese medicine prescription for treating intractable constipation | |
| CN105963597A (en) | Traditional Chinese medicine for treating oral ulcer | |
| CN103611078A (en) | Oral traditional Chinese medicine liquid for treating chronic pelvic inflammation and preparation method thereof | |
| CN104324290A (en) | Traditional Chinese medicine composition for treating pityriasis rosea | |
| CN105169233B (en) | A kind of Chinese medicine composition for treating calculus | |
| CN102048871A (en) | Formula of traditional Chinese medicine for treating renal calculus | |
| CN103417748A (en) | Traditional Chinese medicine composition for treating chronic appendicitis | |
| CN102423434A (en) | Medicament for treating eczema | |
| CN102626491B (en) | Externally used Traditional Chinese medicine composition for treatment of lumbar interveterbral disc protrusion | |
| CN102370753A (en) | Chinese herbal medicine decoction for treating herpes zoster | |
| CN108066635A (en) | A kind of Chinese medicine composition to relax bowel | |
| CN104547246A (en) | Traditional Chinese medicine composition for treating haemorrhoids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140507 Termination date: 20151208 |
|
| EXPY | Termination of patent right or utility model |